Explore the full record of transactions filed by Leonard Braden Michael, Dirigeant. Officer active across 3 companies, notably Gemini Therapeutics, Inc. /DE. Aggregated, 10 disclosures have been published. Total volume traded: €1.8m. The latest transaction was filed on 16 June 2022 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Michael Braden Leonard is an executive at Gemini Therapeutics, Inc., IMARA Inc., and Retractable Technologies Inc. Although his specific role is not specified, he contributes to the leadership and management of operations at these companies. His experience and skills are essential for the strategic development and achievement of business objectives for these firms.